Stock Analysis of Soleno Therapeutics Inc (SLNO) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code SLNO
Close 46.16
Change 0.500 / 1.10 %
Volume 334444
Vol Change 119889 / 55.88 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Soleno Therapeutics Inc
PE (TTM)

-10352.92

Very Poor
Price / Book

7940.70

Very Poor
Price / Sales

156315

Very Poor
Piotroski F Score

3.0

Not Good
Market Cap

1701.52 M

Enterprise Value

1532.11 M

ROA (TTM)

-56.12

Very Poor
ROE (TTM)

-76.70

Very Poor
Net Margin (TTM)

-1509.87

Very Poor
Revenue

%

0
Net Profit

37.86 %

-33178.00 K
Debt to Equity

0.0017

Excellent
Altman Z Score

42.35

Excellent
Quick Ratio

0

Poor
Cash Ratio

14.75

Excellent


Highs/Lows of Soleno Therapeutics Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week44.99 2.60 % 1.54 % 46.8242.2117-May-2413-May-24
Two Week45.12 2.30 % 3.42 % 48.1442.2109-May-2413-May-24
One Month37.9 21.79 % 5.60 % 53.836.6129-Apr-2419-Apr-24
Three Month47.32 2.45 % 5.95 % 53.8236.6128-Feb-2419-Apr-24
Six Months25.77 79.12 % 17.48 % 53.8225.9528-Feb-2420-Nov-23
One year4.3 973.49 % 27.52 % 53.823.6928-Feb-2407-Sep-23
Two year2.8545 1517.10 % 29.70 % 53.820.8528-Feb-2415-Dec-22
Five year29.25 57.81 % 85.46 % 53.820.8528-Feb-2415-Dec-22


Technical View of Soleno Therapeutics Inc
RSI

56.33

Neutral
MACD

1.08

Bullish
ADX

35.99

Mild Bullish
Super Trend

39.44

Mild Bullish
Williams %R

-48.43

Neutral
CCI

41.93

Neutral


EMA 5

45.41

Strong Bullish
EMA 15

44.64

Bullish
EMA 50

43.21

Mild Bullish
EMA 100

40.71

Mild Bullish
SMA 100

43.91

Whipsaw
SMA 200

31.49

Bullish
SMA 5 / 20

44.67 / 43.96

Bullish
SMA 15 / 50

45.80 / 42.42

Strong Bullish
SMA 50 / 200

42.42 / 31.49

Bullish




Charts of Soleno Therapeutics Inc


Returns of Soleno Therapeutics Inc with Peers
Period / StockSLNOVCYTSNDXEWTX
1 Week2.60%7.07%-6.71%-1.20%
1 Mth21.79%21.31%-2.17%15.72%
3 Mth-2.45%-7.52%-9.70%4.26%
6mth79.12%-9.39%32.87%183.41%
1 Year973.49%-8.70%-5.63%94.94%
2 Year1517.10%31.42%38.69%145.39%
5 Years57.81%-6.19%175.68%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Soleno Therapeutics Inc with Peers
Ratio / StockSLNOVCYTSNDXEWTX
PE-10352.92-6099.56-2884.80-2723.57
P/B7940.70386.421580.69807.76
ROA-56.12-5.92-50.19-28.12
ROE-76.70-6.34-54.79-29.66
Debt To Equity0.00170.00490.00190.0031
Revenue0
% 		343149 K
15.72 % 		0
100.00 % 		0
%
Net Income-33178.00 K
37.86 % 		-49955.00 K
36.64 % 		-176081.00 K
17.91 % 		-89435.00 K
32.22 %


Technicals of Soleno Therapeutics Inc with Peers
Technical / StockSLNOVCYTSNDXEWTX-
ADX35.9923.3113.7718.92
CMF-0.2720.0108-0.0960.0386
MFI41.2269.4831.8961.97
RSI56.3362.6639.2151.30
MACD Abv SignalTrueTrueFalseFalse
Price Above 50 MATrueTrueFalseTrue-
Price Above 200 MATrueFalseTrueTrue-


About : Soleno Therapeutics Inc

Address : 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065
Tel : 650 213 8444
URL : https://soleno.life
Code : SLNO, ISIN : US8342032005, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 13_Nov_2014
Employee Count : 33

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)